Drug Resistance, Multiple, Viral
"Drug Resistance, Multiple, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of viruses to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance phenotype may be attributed to multiple gene mutation.
| Descriptor ID |
D024921
|
| MeSH Number(s) |
G06.225.420.500 G06.920.225.500 G07.690.773.984.269.420.500 G07.690.773.984.300.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Multiple, Viral".
- Biological Sciences [G]
- Microbiological Phenomena [G06]
- Drug Resistance, Microbial [G06.225]
- Drug Resistance, Viral [G06.225.420]
- Drug Resistance, Multiple, Viral [G06.225.420.500]
- Virus Physiological Phenomena [G06.920]
- Drug Resistance, Viral [G06.920.225]
- Drug Resistance, Multiple, Viral [G06.920.225.500]
- Physiological Phenomena [G07]
- Pharmacological and Toxicological Phenomena [G07.690]
- Pharmacological Phenomena [G07.690.773]
- Drug Resistance [G07.690.773.984]
- Drug Resistance, Microbial [G07.690.773.984.269]
- Drug Resistance, Viral [G07.690.773.984.269.420]
- Drug Resistance, Multiple, Viral [G07.690.773.984.269.420.500]
- Drug Resistance, Multiple [G07.690.773.984.300]
- Drug Resistance, Multiple, Viral [G07.690.773.984.300.750]
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Multiple, Viral".
This graph shows the total number of publications written about "Drug Resistance, Multiple, Viral" by people in this website by year, and whether "Drug Resistance, Multiple, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 4 | 3 | 7 |
| 2018 | 4 | 4 | 8 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Resistance, Multiple, Viral" by people in Profiles.
-
Compartmentalization of a Multidrug-Resistant Cytomegalovirus UL54 Mutant in a Stem Cell Transplant Recipient with Encephalitis. J Infect Dis. 2019 09 13; 220(8):1302-1306.
-
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients. J Antimicrob Chemother. 2019 05 01; 74(5):1368-1375.
-
Viral resistance in HCV infection. Curr Opin Virol. 2018 10; 32:115-127.
-
Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse. Curr Opin Virol. 2018 10; 32:80-87.
-
HIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-line. Trop Med Int Health. 2018 10; 23(10):1075-1083.
-
Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis. Clin Infect Dis. 2018 08 31; 67(6):962-964.
-
Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA). J Clin Virol. 2018 08; 105:112-117.
-
Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination. AIDS. 2018 06 01; 32(9):F1-F4.
-
GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants. Antimicrob Agents Chemother. 2018 05; 62(5).
-
Neuraminidase inhibitor susceptibility and evolutionary analysis of human influenza B isolates from three Asian countries during 2012-2015. Infect Genet Evol. 2018 08; 62:27-33.